HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma.

Abstract
Mitosis related Aurora-A kinase is amplified in a variety of carcinomas. Overexpression of Aurora-A contributes to tumorigenesis and disease progression, and has emerged as an attractive molecular target for the design of anticancer drugs. In this study, we investigated the function of Aurora-A selectively small molecule inhibitor VX-680 in nasopharyngeal carcinoma (NPC) CNE-2 cells. We found that VX-680 suppressed proliferation and induced apoptosis of 2Dimensional (2D) cultured NPC CNE-2 cells. Moreover, CNE-2 cells formed a tumor-like cell mass in 3Dimensional (3D) matrix culture microenvironment, and the tumor mass formation could be impaired when pretreated with VX-680 for indicated time. Similarly, when adding VX-680 to preformed 3D CNE-2 tumor mass, the tight spatial tumor mass experienced apparent apoptotic cell death and consequently dissociated into individual dead cells, as detected by cleaved Caspase-3 immunofluorescence assay. The migration assay showed that VX-680 decreased NPC CNE-2 cell migration ability in a dose-dependent manner. Our further study revealed that X-ray irradiation and VX-680 upregulated p53 expression level as well as arrested cell cycle in G(2)/M, sensitized NPC CNE-2 cells to radiation and effectively resulted in cell death. In summary, our data indicated that Aurora-A small molecule inhibitor VX-680, potently destructed tumor formation and induced apoptosis, reduced cell migration and enhanced radiosensitivity, offering a promising therapeutic agent for human NPC.
AuthorsXiang-Bo Wan, Xin-Juan Fan, Ming-Yuan Chen, Jie Xu, Zi-Jie Long, Yi-Jun Hua, Hong Ji, Li Liu, Ming-Huang Hong, Yi-Xin Zeng, Quentin Liu
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 8 Issue 15 Pg. 1500-6 (Aug 2009) ISSN: 1555-8576 [Electronic] United States
PMID19502819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Neoplasm Proteins
  • Piperazines
  • Protein Kinase Inhibitors
  • tozasertib
  • Aurora Kinases
  • Protein Serine-Threonine Kinases
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Aurora Kinases
  • Carcinoma (enzymology, pathology)
  • Cell Cycle (drug effects)
  • Cell Division (drug effects)
  • Cell Movement (drug effects)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genes, p53
  • Humans
  • Nasopharyngeal Neoplasms (enzymology, pathology)
  • Neoplasm Proteins (antagonists & inhibitors, physiology)
  • Piperazines (pharmacology)
  • Protein Kinase Inhibitors (pharmacology)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, physiology)
  • Radiation Tolerance (drug effects)
  • Tumor Cells, Cultured (drug effects, enzymology, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: